Work

Clinical-pathologic study of depressive symptoms and cognitive decline in old age

Year: 2014
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: To clarify the relationship between depressive symptoms and the clinical and neuropathologic manifestations of dementia. METHODS: In a clinical-pathologic cohort study, 1,764 older persons without cognitive impairment at enrollment completed annual clinical evaluations for a mean of 7.8 years. The evaluations included assessment of depressive symptoms (10-item Center for Epidemiological Studies Depression Scale) and cognitive function (battery of 17 performance tests). A total of 582 individuals died during follow-up and underwent a uniform neuropathologic examination to quantify β-amyloid plaques and tau tangle density in multiple brain regions and identify neocortical Lewy bodies, hippocampal sclerosis, and gross and microscopic cerebral infarcts. RESULTS: Level of depressive symptoms slightly increased during follow-up. Incident mild cognitive impairment (52.2%) was associated with higher level of depressive symptoms before the diagnosis but not with change in symptoms after the diagnosis; incident dementia (17.9%) was associated with higher symptom level before dementia onset and with more rapid decline in symptoms after dementia onset. None of the neuropathologic markers was related to level of depressive symptoms or change in symptoms over time. In a mixed-effects model adjusted for the neuropathologic markers, higher level of depressive symptoms averaged over evaluations was associated with more rapid global cognitive decline, accounting for 4.4% of the variability in decline not attributable to the neuropathologic markers. Depressive symptoms did not modify the association of the neuropathologic markers with cognitive decline. CONCLUSION: In old age, depressive symptoms have an association with cognitive decline that is independent of the neuropathologic hallmarks of dementia.
Source: Neurology
Language: English
Field: Medicine
Open Access status: bronze
Awards: Brain and Spinal Cord Microvascular Pathology in Late-Life Motor Impairment, Adult Neurological Phenotypes of Fragile X Gray Zone Expansion, Epidemiologic Study of Neural Reserve and Neurobiology of Aging, Role of the Innate Immune System in Aging and Development of Alzheimer's Disease, Rush Center of Excellence on Disparties in HIV and Aging (CEDHA), Epidemiologic Study of TDP-43 Pathology in Aging and Dementia, Targeted Proteomics of Resilient Cognition in Aging, Exploring the Role of the Brain Transcriptome in Cognitive Decline, 10/16 Action for Health in Diabetes Extension Study Research Project, Pathway discovery, validation and compound identification for Alzheimer's disease, ASPirin in Reducing Events in the Elderly, Alzheimer's Disease Core Center, TWO PRECLINICAL LATENT SCORES TO PREDICT OCCURRENCE OF DAT, Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences, Alzheimer's Disease Cooperative Study (ADCS), Altered monocyte function in relation to the CD33 Alzheimers disease locus, Risk Factors, Pathology, and Clinical Expressions of AD, The Clinical Profile of Parkinson's Disease (PD) Pathology, Rush Alzheimer's Disease Core Center, Alzheimer's Disease Genetics Consortium, Alzheimer's Disease Neuroimaging Initiative, BAILA: Being Active, Increasing Latinos healthy Aging, Epidemiology of Familial Late-Onset Alzheimer's Disease, Vascular Cognitive and Motor Decline: Impact of aPL, Stroke and aPL: Community-Based Clinicopathological Study, Genetics of Nicotine Dependence, Influence of Dietary Fish and mercury Exposure on Brain health and Dementia, Role of impaired cognitive states & risk factors in conversion to mixed dementias, Risk Factors, Pathology, and Clinical Expressions of AD, Development of Lewy Bodies Biofluid Signatures by Targeted Proteomics, Epidemiologic Study of Decision Making in Preclinical Alzheimer's Disease, Characterizing the Behavior Profile of Healthy Cognitive Aging, Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease
OpenAlex ID: W2000131852
FWCI: 10.02
Cites: 42
Cited by: 189
Related to: 10